萝莉社

(904) 244-0411 Education Research Community

Treats Adults

Scott L Silliman, MD

Neurologist, Vascular Neurologist

4.9 /5 425 ratings

(904) 383-1022

Request appointment online

Provider profile Menu

Provider profile Menu

Research at a glance

Top areas of exploration

Stroke , 21 publications
Cerebral Hemorrhage , 16 publications
Genetic Predisposition to Disease , 12 publications
Brain Ischemia , 11 publications

Research activity

62 publications

3,916 citations

Why is this important?

Active clinical trials

ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke

Investigators: Benjamin T Alwood, Scott L Silliman
Status: Accepting Candidates
Ages: 18 Years - 90 Years
Sexes: All

ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke

Investigators: Benjamin T Alwood, Scott L Silliman
Status: Accepting Candidates
Ages: 18 Years - 90 Years
Sexes: All

My publications

62 publications

2013

Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage.

Stroke

鈥�

2013

Novel insights into the genetics of intracerebral hemorrhage.

Stroke

鈥�

2013

Characteristics and outcomes of cocaine-related spontaneous intracerebral hemorrhages.

ISRN neurology

鈥�

2013

Common variants within oxidative phosphorylation genes influence risk of ischemic stroke and intracerebral hemorrhage.

Stroke

鈥�

2013

Dysphagia, nutrition, and hydration in ischemic stroke patients at admission and discharge from acute care.

Dysphagia

鈥�